Multivalent pyrrolidines acting as pharmacological chaperones against Gaucher disease.

[Display omitted] • Asymmetric synthesis of two enantiomeric ω-azido- C -alkyl hydroxypyrrolidines via Crabbé-Ma allenation. • Copper-free ligation on cyclooctyne–decorated cyclotriphosphazene-based dendrimers. • Nanomolar dodecavalent inhibitor of GCase. • First example of multivalent pyrrolidines acting as pharmacological chaperones of GCase in Gaucher disease fibroblasts. A concise asymmetric synthesis of clickable enantiomeric pyrrolidines was achieved using Crabbé-Ma allenation. The synthesized iminosugars were grafted by copper–free strain-promoted alkyne-azide cycloaddition onto phosphorus dendrimers. The hexavalent and dodecavalent pyrrolidines were evaluated as β–glucocerebrosidase inhibitors. The level of inhibition suggests that monofluorocyclooctatriazole group may contribute to the affinity for the protein leading to potent multivalent inhibitors. Docking studies were carried out to rationalize these results. Then, the iminosugars clusters were evaluated as pharmacological chaperones in Gaucher patients' fibroblasts. An increase in β–glucocerebrosidase activity was observed with hexavalent and dodecavalent pyrrolidines at concentrations as low as 1 µM and 0.1 µM, respectively. These iminosugar clusters constitute the first example of multivalent pyrrolidines acting as pharmacological chaperones against Gaucher disease. [ABSTRACT FROM AUTHOR]